As a group, American Indians and Alaska Natives (AI/ANs) have the poorest 5-year survival from all cancers among all racial/ethnic groups in the United States, and the Collaborative to Improve Native Cancer Outcomes (CINCO) is working to figure out why and to improve that rate by improving the quality of care for AI/ANs. Led by CERTAIN partner University of Washington Center for Clinical and Epidemiological Research (CCER), CINCO is a research and quality improvement program that aims to improve outcomes and quality of life for people with certain types of cancers, specifically for AI/ANs. Surgery is an important treatment option for common cancers (breast, prostate, colorectal, lung), so CERTAIN developed a module to track the quality and safety of surgery for patients with these types of cancers. Doctors who care for AI/AN patients with cancer can see how their patients are doing and work to improve surgery outcomes.
In addition to the SCOAP module activity, CERTAIN is also conducting a research study that aims to understand how patient and doctor attitudes and beliefs affect their treatment choices and outcomes. When we can better understand how attitudes and beliefs affect care, we can design trainings or other activities to achieve the best possible outcomes of surgery for cancer.
Ardith Doorenbos is an Associate Professor at the University of Washington School of Nursing, and Emily Haozous is an Assistant Professor at the University of New Mexico College of Nursing. They recently sat down with us to answer some questions about their background and why participating in this research study is important to them. See the full interviews here!
CINCO is funded by an award received from the National Cancer Institute (NCI).
CERTAIN is helping patients be certain of the quality of care they receive by:
Contact us to learn more about CERTAIN activities in Cancer Care and find out how you can get involved.
For a list of participating clinicians, click here.